Disease Activity Index
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide
9
The prevalence of vertebral fractures in spondyloarthritis: relation to disease characteristics, bone mineral density, syndesmophytes and history of back pain and trauma
8
Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2 year follow up of a randomized, non blinded, controlled study
12
Effectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritis
10
Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long term open label adalimumab treatment: 3 year results of the ABILITY 1 trial
13
Attainment and characteristics of clinical remission according to the new ACR EULAR criteria in abatacept treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX) naive patients with Early Erosive rheumatoid arthritis (AGREE)
12
Deletion at 2q14 3 is associated with worse response to TNF α blockers in patients with rheumatoid arthritis
7
Cognitive impairment, event-related potentials and immunological status in patients with systemic lupus erythematosus
8
Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis
10
Value of self performed joint counts in rheumatoid arthritis patients near remission
9
Secukinumab provides sustained PASDAS defined remission in psoriatic arthritis and improves health related quality of life in patients achieving remission: 2 year results from the phase III FUTURE 2 study
11
Intercorrelation between MRI disease activity scores of the sacroiliac joints and the spine, and clinical disease activity indices in patients with axial spondyloarthritis
7
Outcome measures in inflammatory rheumatic diseases
10
Eligibility criteria for biologic disease modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI
8
Common Evaluations of Disease Activity in Rheumatoid Arthritis Reach Discordant Classifications across Different Populations
8
Magnetic resonance enterography, colonoscopy, and fecal calprotectin correlate in colonic Crohn’s disease
9
Reliability and validity of CDAI and SDAI indices in comparison to DAS 28 index in Moroccan patients with rheumatoid arthritis
6
A five year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis
14
Depression in ankylosing spondylitis and the role of disease related and contextual factors: a cross sectional study
10
The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people
12